IFITM3 restricts the morbidity and mortality associated with influenza

Everitt, Aaron, Clare, Simon, Pertel, Thomas, John, Sinu, Wash, Rachael, Smith, Sarah, Chin, Christopher, Feeley, Eric, Sims, Jennifer, Adams, David, Wise, Helen, Kane, Leanne, Goulding, David, Digard, Paul, Anttila, Verneri, Baillie, J. Kenneth, Walsh, Tim, Hume, David, Palotie, Aarno, Xue, Yali, Colonna, Vincenza, Tyler-Smith, Chris, Dunning, Jake, Gordon, Stephen ORCID: https://orcid.org/0000-0001-6576-1116, Smyth, Rosalind, Openshaw, Peter, Dougan, Gordon, Brass, Abraham and Kellam, Paul (2012) 'IFITM3 restricts the morbidity and mortality associated with influenza'. Nature, Vol 484, Issue 7395, p. 519523.

Full text not available from this repository.

Abstract

The 2009 H1N1 influenza pandemic showed the speed with which a novel respiratory virus can spread and the ability of a generally mild infection to induce severe morbidity and mortality in a subset of the population. Recent in vitro studies show that the interferon-inducible transmembrane (IFITM) protein family members potently restrict the replication of multiple pathogenic viruses1, 2, 3, 4, 5, 6, 7. Both the magnitude and breadth of the IFITM proteins’ in vitro effects suggest that they are critical for intrinsic resistance to such viruses, including influenza viruses. Using a knockout mouse model8, we now test this hypothesis directly and find that IFITM3 is essential for defending the host against influenza A virus in vivo. Mice lacking Ifitm3 display fulminant viral pneumonia when challenged with a normally low-pathogenicity influenza virus, mirroring the destruction inflicted by the highly pathogenic 1918 ‘Spanish’ influenza9, 10. Similar increased viral replication is seen in vitro, with protection rescued by the re-introduction of Ifitm3. To test the role of IFITM3 in human influenza virus infection, we assessed the IFITM3 alleles of individuals hospitalized with seasonal or pandemic influenza H1N1/09 viruses. We find that a statistically significant number of hospitalized subjects show enrichment for a minor IFITM3 allele (SNP rs12252-C) that alters a splice acceptor site, and functional assays show the minor CC genotype IFITM3 has reduced influenza virus restriction in vitro. Together these data reveal that the action of a single intrinsic immune effector, IFITM3, profoundly alters the course of influenza virus infection in mouse and humans

Item Type:	Article
Corporate Authors:	The GenISIS Investigators, The MOSAIC Investigators
Uncontrolled Keywords:	Virology; Immunology; Health and medicine; Disease
Subjects:	QW Microbiology and Immunology > Viruses > QW 160 Viruses (General). Virology QW Microbiology and Immunology > Immune Responses > QW 700 Infection. Mechanisms of infection and resistance. WC Communicable Diseases > Virus Diseases > Viral Respiratory Tract Infections. Respirovirus Infections > WC 515 Human influenza
Faculty: Department:	Groups (2002 - 2012) > Clinical Group
Digital Object Identifer (DOI):	https://doi.org/10.1038/nature10921
Depositing User:	Users 379 not found.
Date Deposited:	19 Oct 2012 08:45
Last Modified:	07 Oct 2019 08:23
URI:	https://archive.lstmed.ac.uk/id/eprint/3016

Statistics

View details

Actions (login required)

Edit Item